Get Diamond plan for FREE

    logo

    Peak Bio, Inc. (PKBOW)

    Price:

    0.01 USD

    ( + 0.01 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    PKBOW
    Name
    Peak Bio, Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    0.010
    Market Cap
    531.873k
    Enterprise value
    5.623k
    Currency
    USD
    Ceo
    Hoyoung Huh
    Full Time Employees
    6
    Website
    peak-bio.com
    Ipo Date
    2022-11-02
    City
    Palo Alto
    Address
    3350 W Bayshore Rd.

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    BioNTech SE

    VALUE SCORE:

    6

    Symbol
    BNTX
    Market Cap
    22.164B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    3.613B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Aurinia Pharmaceuticals Inc.

    VALUE SCORE:

    12

    Symbol
    AUPH
    Market Cap
    1.842B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    0.001
    P/S
    0
    P/B
    0.350
    Debt/Equity
    0
    EV/FCF
    -0.219
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    874.028
    Debt/assets
    0
    FUNDAMENTALS
    Net debt/ebidta
    -0.000
    Interest coverage
    -1.109
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.000
    Capex to revenue
    0
    Capex to depreciation
    -0.000
    Return on tangible assets
    304.204
    Debt to market cap
    0
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    0.000
    P/CF
    -0.001
    P/FCF
    -0.220
    RoA %
    30.420k
    RoIC %
    -26.633k
    Gross Profit Margin %
    0
    Quick Ratio
    21.476
    Current Ratio
    21.476
    Net Profit Margin %
    0
    Net-Net
    0.006
    FUNDAMENTALS PER SHARE
    FCF per share
    -27.213
    Revenue per share
    0
    Net income per share
    19.666
    Operating cash flow per share
    -27.213
    Free cash flow per share
    -27.213
    Cash per share
    0.006
    Book value per share
    0.064
    Tangible book value per share
    0.064
    Shareholders equity per share
    0.064
    Interest debt per share
    15.453
    TECHNICAL
    52 weeks high
    0.010
    52 weeks low
    0.010
    Current trading session High
    0.010
    Current trading session Low
    0.010
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    CA
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.178
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.405
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.052
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.344
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.002
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    -2.8057056%
    P/E
    -2.537
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.042
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    2.349
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.003
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.084
    DESCRIPTION

    Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

    NEWS